Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 571 AL 585

Talking With Patients About the New Anti-amyloid Alzheimer Disease Medications

Sarkisian CA, Romanov A, Mafi JN.

Ann Intern Med. 2024 Feb;177(2):246-248. doi: 10.7326/M23-3377. Epub 2024 Jan 23.

Which factors preceding dementia identification impact future healthcare use trajectories: multilevel analyses in administrative data

Couret A, Lapeyre-Mestre M, Gombault-Datzenko E, Renoux A, Villars H, Gardette V.

BMC Geriatr. 2024 Jan 23;24(1):89. doi: 10.1186/s12877-023-04643-1.

One carbon metabolism and its implication in health and immune functions

Dang S, Jain A, Dhanda G, Bhattacharya N, Bhattacharya A, Senapati S.

Cell Biochem Funct. 2024 Jan;42(1):e3926. doi: 10.1002/cbf.3926.

Sulfonamide Derivatives: Recent Compounds with Potent Anti-alzheimer's Disease Activity

Egbujor MC.

Cent Nerv Syst Agents Med Chem. 2024;24(1):82-104. doi: 10.2174/0118715249278489231128042135.

The role of ATP-binding cassette transporter G1 (ABCG1) in Alzheimer's disease: A review of the mechanisms

Yazdi MK, Alavi MS, Roohbakhsh A.

Basic Clin Pharmacol Toxicol. 2024 Apr;134(4):423-438. doi: 10.1111/bcpt.13981. Epub 2024 Jan 26.

Disentangling tau: One protein, many therapeutic approaches

Lane-Donovan C, Boxer AL.

Neurotherapeutics. 2024 Mar;21(2):e00321. doi: 10.1016/j.neurot.2024.e00321. Epub 2024 Jan 25.

Converged avenues: depression and Alzheimer's disease- shared pathophysiology and novel therapeutics

Bajaj S, Mahesh R.

Mol Biol Rep. 2024 Jan 28;51(1):225. doi: 10.1007/s11033-023-09170-1.

Lessons Learned from Approval of Aducanumab for Alzheimer's Disease

Heidebrink JL, Paulson HL.

Annu Rev Med. 2024 Jan 29;75:99-111. doi: 10.1146/annurev-med-051022-043645.

Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management

Singh B, Day CM, Abdella S, Garg S.

J Control Release. 2024 Mar;367:402-424. doi: 10.1016/j.jconrel.2024.01.047. Epub 2024 Feb 1.

A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease

Pathak C, Kabra UD.

Bioorg Chem. 2024 Mar;144:107152. doi: 10.1016/j.bioorg.2024.107152. Epub 2024 Jan 27.

Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development

Ahmed H, Wang Y, Griffiths WJ, Levey AI, Pikuleva I, Liang SH, Haider A.

Brain. 2024 May 3;147(5):1622-1635. doi: 10.1093/brain/awae028.

A Comprehensive Review on Potential Molecular Drug Targets for the Management of Alzheimer's Disease

Sharma C, Mazumder A.

Cent Nerv Syst Agents Med Chem. 2024;24(1):45-56. doi: 10.2174/0118715249263300231116062740.

Marine-derived Compounds: A Powerful Platform for the Treatment of Alzheimer's Disease

Arora R, Babbar R, Dabra A, Chopra B, Deswal G, Grewal AS.

Cent Nerv Syst Agents Med Chem. 2024;24(2):166-181. doi: 10.2174/0118715249269050231129103002.

Muscarinic control of cardiovascular function in humans: a review of current clinical evidence

Palma JA.

Clin Auton Res. 2024 Feb;34(1):31-44. doi: 10.1007/s10286-024-01016-5. Epub 2024 Feb 2.

A systematic review and meta-analysis of tau phosphorylation in mouse models of familial Alzheimer's disease

Kourti M, Metaxas A.

Neurobiol Dis. 2024 Mar;192:106427. doi: 10.1016/j.nbd.2024.106427. Epub 2024 Feb 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias